期刊文献+

盐酸普萘洛尔乳膏的研制及质量标准研究 被引量:3

Preparation and quality control of propranolol hydrochloride cream
下载PDF
导出
摘要 目的优选盐酸普萘洛尔乳膏的最佳基质配方和工艺条件,并对其进行质量控制。方法以乳化温度、硬脂酸、单硬脂酸甘油酯及吐温-80用量为考察因素,采用正交试验优选最佳基质配方和工艺条件;采用HPLC法测定盐酸普萘洛尔的含量,并对其进行质量控制。结果筛选出了最佳基质配方和工艺条件为硬脂酸10%,单硬脂酸甘油酯7.5%,吐温-803%,乳化温度70℃,制备的盐酸普萘洛尔乳膏外观及稳定性均良好,质量可靠,平均回收率为98.65%,RSD为0.52%(n=9)。结论盐酸普萘洛尔乳膏制备工艺可行,质量稳定,质控方法简便快速。 Objective To optimize matrix formula and process conditions and control the quality of propranolol hydrochloride cream. Methods Emulsifying temperature, dosages of the stearic acid, glyceryl monostearate and Tween-80 were taken as variable factors and the orthogonal experiment was adopted to optimize matrix formula and process conditions. HPLC was chosen to determine the content of propranolol hydrochloride and control its quality. Results The optimized matrix formula of propranolol hydrochloride cream was composed of 10% of stearic acid, 7.5% of glyeeryl monostearate, 3% of Tween-80 and emulsifying temperature was 70 ℃. The appearance and stability were good and the quality was good. The average recovery rate was 98.65% , RSD was 0.52% ( n = 9). Conclusion The preparation process of propranolol hydrochloride cream was rational and stable in quality. The quality control method was simple and fast.
出处 《药学实践杂志》 CAS 2013年第6期409-411,435,共4页 Journal of Pharmaceutical Practice
基金 山东省科技发展项目(2012YD18056)
关键词 盐酸普萘洛尔 乳膏 正交试验 制备 HPLC 质量控制 propranolol hydrochloride cream orthogonal experiment preparation HPLC quality control
  • 相关文献

参考文献3

二级参考文献21

  • 1Haggstrom AN Drolet BA.婴幼儿血管瘤的前瞻性研究:人口统计学及围产期特点[J].中国口腔颌面外科杂志,2007,5(3):179-179. 被引量:16
  • 2Bennett ML, Fleischer AB, Chamlin SL, et al. Oral corticosteroid use is effective for cutaneous hemangiomas : an evidence-based eval- uation [ J ]. Arch Dermatol, 2001,137 (9) : 1208-1213.
  • 3Ezekowitz RAB,Mulliken JB, Folkman J. Interferon alpha 2α thera- py for life threatening hemangiomas of infancy [ J ]. NEJM, 1992, 326(22) :1456-1463.
  • 4Enjolras O, Breviere GM, Roger G, et al. Vincristine treatment for function-and life-threatening infantile hemangioma [ J 1. Arch Pedi- atr, 2004,11 (2) :99-107.
  • 5Waner M, Srun JY. Hemangiomas and vascular malformations of the head and neck[ M]. New York: Wiley-Iiss,1999:1-12.
  • 6Achauer BM, Chang CJ, Vander Kam VM. Management of heman- gioma of infancy : review of 245 patients [ J ]. Plast Reconstr Surg, 1997,99(5) :1301-1308.
  • 7Leaute-Labreze C, Dumas dela Roque E, Hubiche T, et al. Prop- ranolol for severe hemangiomas of infancy [ J ]. NEJM, 2008,358 (24) :2649-2651.
  • 8Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for aiway hemangiomas :case report of nover treatment [ J ]. Laryngoscope, 2009,119 ( 10 ) :2051-2054.
  • 9Leaute-Labreze C, Taieb A. Efficacy of beta-blockers in infantile hemangigomas: The physiopathological significance and therapertic consequences[ J ]. Ann Dermatol Venerol, 2008,135 (12) :860- 862.
  • 10Metry D.Update on hemangiomas of infancy[J].Curt opin pediatr,2004,16(4):373 -377.

共引文献31

同被引文献32

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部